ZP3
geneOn this page
Also known as ZP3-424ZP3-372ZPC
Summary
ZP3 (zona pellucida glycoprotein 3, HGNC:13189) is a protein-coding gene on chromosome 7q11.23, encoding Zona pellucida sperm-binding protein 3 (P21754). Component of the zona pellucida, an extracellular matrix surrounding oocytes which mediates sperm binding, induction of the acrosome reaction and prevents post-fertilization polyspermy.
The zona pellucida is an extracellular matrix that surrounds the oocyte and early embryo. It is composed primarily of three or four glycoproteins with various functions during fertilization and preimplantation development. The protein encoded by this gene is a structural component of the zona pellucida and functions in primary binding and induction of the sperm acrosome reaction. The nascent protein contains a N-terminal signal peptide sequence, a conserved ZP domain, a C-terminal consensus furin cleavage site, and a transmembrane domain. It is hypothesized that furin cleavage results in release of the mature protein from the plasma membrane for subsequent incorporation into the zona pellucida matrix. However, the requirement for furin cleavage in this process remains controversial based on mouse studies. A variation in the last exon of this gene has previously served as the basis for an additional ZP3 locus; however, sequence and literature review reveals that there is only one full-length ZP3 locus in the human genome. Another locus encoding a bipartite transcript designated POMZP3 contains a duplication of the last four exons of ZP3, including the above described variation, and maps closely to this gene.
Source: NCBI Gene 7784 — RefSeq curated summary.
At a glance
- Gene–disease (curated): oocyte maturation defect 3 (Strong, GenCC) — +2 more curated relationships
- GWAS associations: 1
- Clinical variants (ClinVar): 122 total — 4 pathogenic, 1 likely-pathogenic
- Phenotypes (HPO): 3
- MANE Select transcript:
NM_001110354
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13189 |
| Approved symbol | ZP3 |
| Name | zona pellucida glycoprotein 3 |
| Location | 7q11.23 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | ZP3-424, ZP3-372, ZPC |
| Ensembl gene | ENSG00000188372 |
| Ensembl biotype | protein_coding |
| OMIM | 182889 |
| Entrez | 7784 |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 4 protein_coding, 2 protein_coding_CDS_not_defined, 1 retained_intron
ENST00000336517, ENST00000394857, ENST00000394860, ENST00000416245, ENST00000466960, ENST00000467555, ENST00000479793
RefSeq mRNA: 2 — MANE Select: NM_001110354
NM_001110354, NM_007155
CCDS: CCDS47618, CCDS5586
Canonical transcript exons
ENST00000394857 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000918820 | 76429515 | 76429633 |
| ENSE00000918822 | 76433470 | 76433647 |
| ENSE00001519824 | 76424950 | 76425276 |
| ENSE00002523186 | 76434038 | 76434155 |
| ENSE00003642301 | 76440250 | 76440341 |
| ENSE00003668067 | 76432927 | 76433030 |
| ENSE00003668475 | 76440475 | 76440611 |
| ENSE00003850385 | 76441842 | 76442069 |
Expression profiles
Bgee: expression breadth ubiquitous, 134 present calls, max score 89.00.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.8765 / max 74.8760, expressed in 971 samples.
FANTOM5 promoters (8 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 79168 | 2.2400 | 765 |
| 79171 | 0.5660 | 294 |
| 79167 | 0.3984 | 222 |
| 79169 | 0.2246 | 125 |
| 79170 | 0.1794 | 100 |
| 79173 | 0.1328 | 65 |
| 79172 | 0.1137 | 50 |
| 79175 | 0.0214 | 7 |
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| lower esophagus mucosa | UBERON:0035834 | 89.00 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 84.23 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.49 | gold quality |
| apex of heart | UBERON:0002098 | 83.07 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 82.35 | gold quality |
| bone marrow cell | CL:0002092 | 80.09 | gold quality |
| ventricular zone | UBERON:0003053 | 79.03 | gold quality |
| muscle tissue | UBERON:0002385 | 78.67 | gold quality |
| body of pancreas | UBERON:0001150 | 78.62 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 78.46 | gold quality |
| esophagus mucosa | UBERON:0002469 | 78.30 | gold quality |
| nucleus accumbens | UBERON:0001882 | 78.11 | gold quality |
| fundus of stomach | UBERON:0001160 | 78.10 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 77.98 | gold quality |
| mucosa of stomach | UBERON:0001199 | 77.98 | gold quality |
| putamen | UBERON:0001874 | 77.69 | gold quality |
| right uterine tube | UBERON:0001302 | 77.67 | gold quality |
| skin of leg | UBERON:0001511 | 77.36 | gold quality |
| zone of skin | UBERON:0000014 | 77.15 | gold quality |
| right adrenal gland | UBERON:0001233 | 76.88 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 76.88 | gold quality |
| blood | UBERON:0000178 | 76.74 | gold quality |
| skin of abdomen | UBERON:0001416 | 76.68 | gold quality |
| vagina | UBERON:0000996 | 76.67 | gold quality |
| corpus callosum | UBERON:0002336 | 76.40 | gold quality |
| left adrenal gland | UBERON:0001234 | 76.36 | gold quality |
| thoracic mammary gland | UBERON:0005200 | 76.26 | gold quality |
| pancreas | UBERON:0001264 | 76.21 | gold quality |
| left ovary | UBERON:0002119 | 76.19 | gold quality |
| ectocervix | UBERON:0012249 | 76.09 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-8381 | yes | 2069.79 |
| E-GEOD-36552 | yes | 411.72 |
| E-ANND-3 | no | 2.35 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): FIGLA, SOHLH1
Literature-anchored findings (GeneRIF, showing 26)
- Eggs expressing glycoprotein huZP3, derived from transgenic mice, bind murine but not human sperm, implying that huZP3 acquires the same O-glycans as native mZP3. (PMID:14673092)
- human and mouse ZP3 proteins are quite similar, and alternative explanations of taxon-specific sperm binding warrant exploration (PMID:15379548)
- Binding sites for recombinant zona pellucida C (ZPC) glycoprotein are located both at the N- and C-terminus of proacrosin (PMID:15950651)
- Exposure of sperm to ZP proteins promoted acrosomal exocytosis and changed motility patterns. (PMID:16407501)
- Peptides rhuZP3a22 approximately 176 and rhuZP3b177 approximately 348 have a role similar to human ZP3. The mechanism of the response to the peptides involves influx of calcium, the G protein pathway, and a T-type calcium channel. (PMID:17192598)
- ZP proteins were detected in both the oocyte and the granulosa cells as early as the primordial follicle stage in the human. The detection of ZP proteins in the quiescent primordial follicle suggests that these proteins have been present since oogenesis. (PMID:18033806)
- may have a role in the development of primordial follicle before zona pellucida formation (PMID:18502569)
- induces acrosome reactions which are protein kinase-C, protein tyrosine kinase, T-type Ca2+ channels, and extracellular Ca2+ dependent (PMID:18667750)
- a significant decrease in acrosomal exocytosis mediated by both recombinant human ZP3 (p<0.005) and ZP4 (p<0.005) was observed in presence of the immune sera (PMID:19004505)
- The functional activity of human ZP3 resides in its C-terminal domain. (PMID:19246320)
- observed sequence variations in exons of ZP3 gene in women with infertility of unknown origin who exhibit abnormal zona pellucida; sperm-ovum interactions appear relatively normal in these patients [CASE REPORTS] (PMID:22889493)
- Epididymal CRISP1 mediates sperm-zona pellucida binding through its interaction with ZP3. (PMID:24334245)
- The oocyte ZP3 expression was the main predictor of the fertilization capacity. (PMID:28204536)
- Mutations in ZP2 and ZP3 have dosage effects which can cause female infertility in humans. (PMID:28646452)
- Missense Mutation in ZP3 gene is associated with Empty Follicle Syndrome and Female Infertility. (PMID:28886344)
- The zona pellucida-3 (ZP3) protein plays a pivotal role in oocyte and gamete development. (PMID:30341457)
- Mutations in ZP1, ZP2, and ZP3 might affect the corresponding protein expression, secretion, and interaction, thus providing a mechanistic explanation for the phenotypes for female infertility. (PMID:30810869)
- Zona Pellucida Proteins, Fibrils, and Matrix. (PMID:32569527)
- Heterozygous mutations in ZP1 and ZP3 cause formation disorder of ZP and female infertility in human. (PMID:32573113)
- A novel mutation in ZP3 causes empty follicle syndrome and abnormal zona pellucida formation. (PMID:33140178)
- A novel homozygous variant in ZP2 causes abnormal zona pellucida formation and female infertility. (PMID:33604805)
- Novel expression of zona pellucida 3 protein in normal testis; potential functional implications. (PMID:34736966)
- A novel gene mutation in ZP3 loop region identified in patients with empty follicle syndrome. (PMID:34816529)
- Novel mutations in ZP2 and ZP3 cause female infertility in three patients. (PMID:35366744)
- Novel mutations in TUBB8 and ZP3 cause human oocyte maturation arrest and female infertility. (PMID:36335766)
- Novel variants in ZP1, ZP2 and ZP3 associated with empty follicle syndrome and abnormal zona pellucida. (PMID:36931917)
Cross-species orthologs
9 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | zp3e | ENSDARG00000016908 |
| danio_rerio | zp3b | ENSDARG00000039828 |
| danio_rerio | zp3a.1 | ENSDARG00000042129 |
| danio_rerio | zp3a.2 | ENSDARG00000042130 |
| danio_rerio | zp3.2 | ENSDARG00000090768 |
| danio_rerio | zp3 | ENSDARG00000114958 |
| danio_rerio | zp3.2 | ENSDARG00000115457 |
| mus_musculus | Zp3 | ENSMUSG00000004948 |
| rattus_norvegicus | Zp3 | ENSRNOG00000001434 |
Paralogs (1): POMZP3 (ENSG00000146707)
Protein
Protein identifiers
Zona pellucida sperm-binding protein 3 — P21754 (reviewed: P21754)
Alternative names: Sperm receptor, ZP3A/ZP3B, Zona pellucida glycoprotein 3, Zona pellucida protein C
All UniProt accessions (3): P21754, E9PFI9, H0Y3M4
UniProt curated annotations — full annotation on UniProt →
Function. Component of the zona pellucida, an extracellular matrix surrounding oocytes which mediates sperm binding, induction of the acrosome reaction and prevents post-fertilization polyspermy. The zona pellucida is composed of 3 to 4 glycoproteins, ZP1, ZP2, ZP3, and ZP4. ZP3 is essential for sperm binding and zona matrix formation.
Subunit / interactions. Polymers of ZP2 and ZP3 organized into long filaments cross-linked by ZP1 homodimers. Interacts with ZP1 and ZP2.
Subcellular location. Zona pellucida Cell membrane.
Tissue specificity. Expressed in oocytes (at protein level).
Post-translational modifications. Proteolytically cleaved before the transmembrane segment to yield the secreted ectodomain incorporated in the zona pellucida. N-glycosylated. O-glycosylated; removal of O-linked glycans may play an important role in the post-fertilization block to polyspermy.
Disease relevance. Oocyte/zygote/embryo maturation arrest 3 (OZEMA3) [MIM:617712] An autosomal dominant infertility disorder characterized by abnormal oocytes that lack the zona pellucida, and oocytes degeneration. The disease is caused by variants affecting the gene represented in this entry.
Domain organisation. The ZP domain is involved in the polymerization of the ZP proteins to form the zona pellucida.
Miscellaneous. Found in a second polymorphic locus which, due to an extra G residue in exon 8, has the potential to encode a truncated protein of 372 amino acids.
Similarity. Belongs to the ZP domain family. ZPC subfamily.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| P21754-1 | ZP3A | yes |
| P21754-2 | ZP3B | |
| P21754-3 | 3 |
RefSeq proteins (2): NP_001103824, NP_009086 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001507 | ZP_dom | Domain |
| IPR017977 | ZP_dom_CS | Conserved_site |
| IPR042235 | ZP-C_dom | Homologous_superfamily |
| IPR048290 | ZP_chr | Domain |
| IPR055355 | ZP-C | Domain |
| IPR055356 | ZP-N | Domain |
Pfam: PF00100, PF23344
UniProt features (28 total): glycosylation site 6, disulfide bond 4, sequence variant 4, splice variant 3, chain 2, topological domain 2, signal peptide 1, sequence conflict 1, propeptide 1, transmembrane region 1, domain 1, region of interest 1, modified residue 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P21754-F1 | 77.32 | 0.52 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 23
Disulfide bonds (4): 46–140, 78–99, 217–282, 239–300
Glycosylation sites (6): 125, 147, 156, 162, 163, 272
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-2534343 | Interaction With Cumulus Cells And The Zona Pellucida |
MSigDB gene sets: 234 (showing top):
GOBP_REGULATION_OF_CELL_ACTIVATION, GOBP_SINGLE_FERTILIZATION, GOBP_NEGATIVE_REGULATION_OF_REPRODUCTIVE_PROCESS, GOBP_REGULATION_OF_LEUKOCYTE_PROLIFERATION, GOBP_POSITIVE_REGULATION_OF_REPRODUCTIVE_PROCESS, GOBP_EMBRYO_DEVELOPMENT_ENDING_IN_BIRTH_OR_EGG_HATCHING, GOBP_REGULATION_OF_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS, GOBP_POSITIVE_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE, GOBP_POSITIVE_REGULATION_OF_CALCIUM_ION_DEPENDENT_EXOCYTOSIS, GOBP_INFLAMMATORY_RESPONSE, KAAB_FAILED_HEART_ATRIUM_DN, GOBP_REGULATION_OF_DEVELOPMENTAL_GROWTH, GOBP_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE, GOBP_GROWTH, GOBP_OOGENESIS
GO Biological Process (21): positive regulation of type IV hypersensitivity (GO:0001809), blastocyst formation (GO:0001825), humoral immune response mediated by circulating immunoglobulin (GO:0002455), positive regulation of leukocyte migration (GO:0002687), positive regulation of humoral immune response (GO:0002922), binding of sperm to zona pellucida (GO:0007339), positive regulation of type II interferon production (GO:0032729), positive regulation of interleukin-4 production (GO:0032753), egg coat formation (GO:0035803), positive regulation of T cell proliferation (GO:0042102), negative regulation of DNA-templated transcription (GO:0045892), positive regulation of DNA-templated transcription (GO:0045893), oocyte development (GO:0048599), positive regulation of inflammatory response (GO:0050729), positive regulation of acrosome reaction (GO:2000344), negative regulation of binding of sperm to zona pellucida (GO:2000360), positive regulation of acrosomal vesicle exocytosis (GO:2000368), positive regulation of ovarian follicle development (GO:2000386), positive regulation of antral ovarian follicle growth (GO:2000388), signal transduction (GO:0007165), single fertilization (GO:0007338)
GO Molecular Function (7): extracellular matrix structural constituent (GO:0005201), carbohydrate binding (GO:0030246), acrosin binding (GO:0032190), structural constituent of egg coat (GO:0035804), identical protein binding (GO:0042802), receptor ligand activity (GO:0048018), protein binding (GO:0005515)
GO Cellular Component (6): extracellular region (GO:0005576), obsolete extracellular space (GO:0005615), plasma membrane (GO:0005886), extracellular matrix (GO:0031012), egg coat (GO:0035805), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Fertilization | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| positive regulation of reproductive process | 3 |
| humoral immune response | 2 |
| positive regulation of cytokine production | 2 |
| DNA-templated transcription | 2 |
| regulation of DNA-templated transcription | 2 |
| binding | 2 |
| cellular anatomical structure | 2 |
| type IV hypersensitivity | 1 |
| regulation of type IV hypersensitivity | 1 |
| positive regulation of T cell mediated immunity | 1 |
| positive regulation of hypersensitivity | 1 |
| blastocyst development | 1 |
| anatomical structure formation involved in morphogenesis | 1 |
| immunoglobulin mediated immune response | 1 |
| positive regulation of immune system process | 1 |
| regulation of leukocyte migration | 1 |
| positive regulation of cell migration | 1 |
| leukocyte migration | 1 |
| regulation of humoral immune response | 1 |
| positive regulation of immune response | 1 |
| sperm-egg recognition | 1 |
| type II interferon production | 1 |
| regulation of type II interferon production | 1 |
| interleukin-4 production | 1 |
| regulation of interleukin-4 production | 1 |
| cellular process involved in reproduction in multicellular organism | 1 |
| oogenesis | 1 |
| T cell proliferation | 1 |
| regulation of T cell proliferation | 1 |
| positive regulation of lymphocyte proliferation | 1 |
| positive regulation of T cell activation | 1 |
| negative regulation of RNA biosynthetic process | 1 |
| positive regulation of RNA biosynthetic process | 1 |
| germ cell development | 1 |
| oocyte differentiation | 1 |
| inflammatory response | 1 |
| positive regulation of defense response | 1 |
| positive regulation of response to external stimulus | 1 |
| regulation of inflammatory response | 1 |
| acrosome reaction | 1 |
Protein interactions and networks
STRING
758 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZP3 | ZP1 | P60852 | 999 |
| ZP3 | ZP4 | Q12836 | 999 |
| ZP3 | ZP2 | Q05996 | 990 |
| ZP3 | PKDREJ | Q9NTG1 | 939 |
| ZP3 | PLAC1 | Q9HBJ0 | 885 |
| ZP3 | GDF9 | O60383 | 789 |
| ZP3 | SNU13 | P55769 | 763 |
| ZP3 | ZAN | Q9Y493 | 759 |
| ZP3 | IZUMO1 | Q8IYV9 | 754 |
| ZP3 | NOBOX | O60393 | 743 |
| ZP3 | FIGLA | Q6QHK4 | 734 |
| ZP3 | DAZL | Q92904 | 660 |
| ZP3 | BMP15 | O95972 | 657 |
| ZP3 | CACNA1G | O43497 | 642 |
| ZP3 | ASTL | Q6HA08 | 632 |
IntAct
31 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZP3 | ZP3 | psi-mi:“MI:0407”(direct interaction) | 0.600 |
| ZP3 | VDAC2 | psi-mi:“MI:0915”(physical association) | 0.520 |
| ZP3 | UBAP2L | psi-mi:“MI:0915”(physical association) | 0.490 |
| ZP3 | SPACA3 | psi-mi:“MI:0915”(physical association) | 0.490 |
| ZP3 | PCDH17 | psi-mi:“MI:0915”(physical association) | 0.490 |
| ZP3 | MICALL1 | psi-mi:“MI:0915”(physical association) | 0.490 |
| ZP3 | ACR | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| ZP3 | ODF2 | psi-mi:“MI:0915”(physical association) | 0.400 |
| ZP3 | TPI1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| ZP3 | GSTM3 | psi-mi:“MI:0915”(physical association) | 0.400 |
| ZP3 | GAPDHS | psi-mi:“MI:0915”(physical association) | 0.400 |
| ZP3 | GPX4 | psi-mi:“MI:0915”(physical association) | 0.400 |
| ZP3 | PKM | psi-mi:“MI:0915”(physical association) | 0.400 |
| ZP3 | ENO1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| ZP1 | ZP3 | psi-mi:“MI:0914”(association) | 0.350 |
| ZP2 | ZP3 | psi-mi:“MI:0914”(association) | 0.350 |
| ZP3 | ZP1 | psi-mi:“MI:0914”(association) | 0.350 |
| ZP3 | SERPINB8 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (16): ZP3 (Affinity Capture-RNA), ZP3 (Affinity Capture-RNA), ZP3 (Two-hybrid), ZP3 (Two-hybrid), FAM63A (Affinity Capture-MS), GET4 (Affinity Capture-MS), SERPINB8 (Affinity Capture-MS), ZP3 (Positive Genetic), ZP3 (Affinity Capture-RNA), UBAP2L (Two-hybrid), MRPS16 (Two-hybrid), SPACA3 (Two-hybrid), OR2L13 (Two-hybrid), PCDH17 (Two-hybrid), MICALL1 (Two-hybrid)
ESM2 similar proteins: G7PWZ3, I6M4H4, O08852, O54766, O77726, O95428, P08751, P10761, P17813, P20239, P21754, P23491, P35054, P37176, P42098, P42099, P43021, P47983, P47984, P48829, P48830, P48831, P48832, P48833, P48834, P53785, P53786, P60852, P79762, P97708, Q00193, Q05996, Q07104, Q07287, Q12836, Q3HRV3, Q3S2X5, Q5DID0, Q5DID3, Q62005
Diamond homologs: G5E8D7, P21754, P53785, Q925U0, P10761, P23491, P42098, P48830, P48831, P48832, P48833, P53786, P79762, P97708, Q6PJE2, Q60997, Q8CIZ5, Q95218, A8CG34, P52591, Q8K3Z9, Q96HA1, Q96KW2
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| SOHLH1 | “up-regulates quantity by expression” | ZP3 | “transcriptional regulation” |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 16 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| binding of sperm to zona pellucida | 5 | 131.7× | 2e-08 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
122 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 4 |
| Likely pathogenic | 1 |
| Uncertain significance | 78 |
| Likely benign | 13 |
| Benign | 10 |
Top pathogenic / likely-pathogenic (5)
| Variant ID | HGVS | Classification |
|---|---|---|
| 1285239 | NM_001110354.2(ZP3):c.499GAG[1] (p.Glu168del) | Pathogenic |
| 1711657 | NM_001110354.2(ZP3):c.831+1G>C | Pathogenic |
| 437933 | NM_001110354.2(ZP3):c.400G>A (p.Ala134Thr) | Pathogenic |
| 689403 | NM_001110354.2(ZP3):c.763C>G (p.Arg255Gly) | Pathogenic |
| 1333775 | NM_001110354.2(ZP3):c.157dup (p.Val53fs) | Likely pathogenic |
SpliceAI
1836 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:76397833:C:CA | acceptor_loss | 1.0000 |
| 7:76397834:T:A | acceptor_loss | 1.0000 |
| 7:76398714:A:AC | donor_gain | 1.0000 |
| 7:76398715:C:CC | donor_gain | 1.0000 |
| 7:76398715:CGT:C | donor_gain | 1.0000 |
| 7:76398715:CGTA:C | donor_gain | 1.0000 |
| 7:76398716:GTA:G | donor_loss | 1.0000 |
| 7:76398717:TA:T | donor_loss | 1.0000 |
| 7:76398718:A:AC | donor_gain | 1.0000 |
| 7:76398719:C:CT | donor_gain | 1.0000 |
| 7:76398719:CT:C | donor_gain | 1.0000 |
| 7:76398719:CTT:C | donor_gain | 1.0000 |
| 7:76398719:CTTT:C | donor_gain | 1.0000 |
| 7:76398795:ATTC:A | acceptor_loss | 1.0000 |
| 7:76398796:TT:T | acceptor_gain | 1.0000 |
| 7:76398797:TCT:T | acceptor_loss | 1.0000 |
| 7:76398798:C:CC | acceptor_gain | 1.0000 |
| 7:76398799:T:C | acceptor_loss | 1.0000 |
| 7:76409409:CATA:C | donor_loss | 1.0000 |
| 7:76409410:ATAC:A | donor_loss | 1.0000 |
| 7:76409411:TA:T | donor_loss | 1.0000 |
| 7:76409413:C:CG | donor_loss | 1.0000 |
| 7:76425273:GCAG:G | donor_gain | 1.0000 |
| 7:76425274:CAGGT:C | donor_loss | 1.0000 |
| 7:76425276:GGT:G | donor_loss | 1.0000 |
| 7:76425277:G:GG | donor_gain | 1.0000 |
| 7:76425277:GT:G | donor_loss | 1.0000 |
| 7:76425278:T:A | donor_loss | 1.0000 |
| 7:76429510:TCCA:T | acceptor_loss | 1.0000 |
| 7:76429512:CAGG:C | acceptor_loss | 1.0000 |
AlphaMissense
2790 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:76440312:G:C | K298N | 0.997 |
| 7:76440312:G:T | K298N | 0.997 |
| 7:76434076:T:G | F251C | 0.996 |
| 7:76434039:T:A | C239S | 0.995 |
| 7:76434040:G:C | C239S | 0.995 |
| 7:76429620:T:A | C140S | 0.994 |
| 7:76429621:G:C | C140S | 0.994 |
| 7:76434112:T:C | F263S | 0.994 |
| 7:76440263:G:A | C282Y | 0.994 |
| 7:76440264:C:G | C282W | 0.994 |
| 7:76440316:T:A | C300S | 0.994 |
| 7:76440317:G:C | C300S | 0.994 |
| 7:76433583:T:A | C217S | 0.993 |
| 7:76433584:G:C | C217S | 0.993 |
| 7:76440262:T:A | C282S | 0.993 |
| 7:76440262:T:C | C282R | 0.993 |
| 7:76440263:G:C | C282S | 0.993 |
| 7:76440478:G:C | W309C | 0.993 |
| 7:76440478:G:T | W309C | 0.993 |
| 7:76434075:T:C | F251L | 0.992 |
| 7:76434077:C:A | F251L | 0.992 |
| 7:76434077:C:G | F251L | 0.992 |
| 7:76434133:T:G | F270C | 0.992 |
| 7:76440269:T:C | L284P | 0.992 |
| 7:76433584:G:A | C217Y | 0.991 |
| 7:76434039:T:C | C239R | 0.991 |
| 7:76433585:C:G | C217W | 0.990 |
| 7:76434076:T:C | F251S | 0.989 |
| 7:76434126:T:C | F268L | 0.989 |
| 7:76434128:C:A | F268L | 0.989 |
dbSNP variants (sampled 300 via entrez): RS1000029426 (7:76414463 C>G), RS1000104374 (7:76427838 G>A), RS1000116853 (7:76414070 C>G,T), RS1000193036 (7:76420027 C>G), RS1000303488 (7:76425748 T>C), RS1000484199 (7:76414057 C>G,T), RS1000490195 (7:76430454 G>A), RS1000614217 (7:76433577 G>A), RS1000614248 (7:76397660 G>A), RS1000643648 (7:76433797 T>C,G), RS1000716146 (7:76429025 C>T), RS1000827265 (7:76409872 T>A), RS1000895507 (7:76414414 G>A,T), RS1001020356 (7:76436577 A>G,T), RS1001060809 (7:76401868 T>C)
Disease associations
OMIM: gene MIM:182889 | disease phenotypes: MIM:617712
GenCC curated gene-disease
| Disease | Classification | Inheritance |
|---|---|---|
| oocyte maturation defect 3 | Strong | Autosomal dominant |
| female infertility due to zona pellucida defect | Supportive | Autosomal dominant |
| inherited oocyte maturation defect | Limited | Autosomal recessive |
Mondo (3): oocyte maturation defect 3 (MONDO:0021574), inherited oocyte maturation defect (MONDO:0014769), female infertility due to zona pellucida defect (MONDO:0014342)
Orphanet (0):
HPO phenotypes
3 total (3 of 3 shown, HPO-id order):
| HPO | Term |
|---|---|
| HP:0000006 | Autosomal dominant inheritance |
| HP:0008222 | Female infertility |
| HP:0011462 | Young adult onset |
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002778_4 | Parkinson disease and lewy body pathology | 7.000000e-07 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
27 total (human), top 27 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Aflatoxin B1 | decreases methylation, increases expression | 3 |
| Smoke | increases abundance, decreases expression | 2 |
| Tretinoin | decreases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| ethyl-p-hydroxybenzoate | decreases expression | 1 |
| sulforaphane | increases expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| S-(1,2-dichlorovinyl)cysteine | affects cotreatment, increases expression | 1 |
| ICG 001 | increases expression | 1 |
| 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide | affects cotreatment, increases expression | 1 |
| jinfukang | increases expression | 1 |
| Temozolomide | increases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Arsenic | affects methylation | 1 |
| Azacitidine | increases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Hydrogen Peroxide | affects expression | 1 |
| Lipopolysaccharides | affects cotreatment, increases expression | 1 |
| Mustard Gas | increases expression | 1 |
| Ozone | increases expression | 1 |
| Rotenone | increases expression | 1 |
| Tetrachlorodibenzodioxin | affects cotreatment, increases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Triclosan | increases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | increases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 spontaneously immortalized cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_K172 | HuZP3-CHOLec3.2.8.1 | Spontaneously immortalized cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Associated diseases: inherited oocyte maturation defect, oocyte maturation defect 3, female infertility due to zona pellucida defect
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): female infertility due to zona pellucida defect, inherited oocyte maturation defect, oocyte maturation defect 3, Parkinson disease